Announcements Trials
Browse Landscape

Phase

Phase 4 4

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Constipation 1Colorectal Neoplasms 1Colorectal Cancer Screening 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × polyethylene glycol 3350 × Clear all
NCT07215000 2025-10-09

COOP SIT

Morehouse School of Medicine

Phase 4 Recruiting
300 enrolled
Gastrointestinal

Colorectal Cancer Screening

NCT05805436 2025-05-30

Preop Laxatives in Robotic Urologic Surgery

University of Iowa

Phase 4 Recruiting
240 enrolled
GenitourinaryOther

Constipation, Kidney Neoplasms, Prostatic Neoplasms

NCT01170754 2017-09-13

Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

Temple University

Phase 4 Completed
136 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms

NCT00626054 2016-04-13

PEG

Rabin Medical Center

Phase 4 Completed
400 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡